11th Sep 2020 14:00
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 10 September 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,199,784 | 1.71% | 467,185 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
355,000 | 0.28% | 393,389 | 0.31% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,554,784 | 1.98% | 860,574 | 0.67% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 27 | 210.7400 USD |
Purchase | 43 | 209.2700 USD |
Purchase | 55 | 211.3943 USD |
Purchase | 100 | 209.0500 USD |
Purchase | 100 | 210.7900 USD |
Purchase | 100 | 210.1900 USD |
Purchase | 131 | 210.0003 USD |
Purchase | 553 | 207.3135 USD |
Purchase | 600 | 209.7200 USD |
Purchase | 628 | 210.6118 USD |
Purchase | 2,341 | 210.8825 USD |
Purchase | 3,169 | 209.0983 USD |
Purchase | 3,458 | 208.7853 USD |
Purchase | 3,899 | 211.0234 USD |
Purchase | 4,228 | 211.3803 USD |
Purchase | 4,321 | 207.2700 USD |
Purchase | 6,068 | 207.3526 USD |
Purchase | 6,275 | 207.8348 USD |
Purchase | 8,125 | 209.4363 USD |
Purchase | 8,300 | 209.8103 USD |
Purchase | 49,290 | 209.1249 USD |
Sale | 100 | 210.1650 USD |
Sale | 100 | 209.3000 USD |
Sale | 100 | 209.3100 USD |
Sale | 100 | 210.1900 USD |
Sale | 100 | 209.2500 USD |
Sale | 100 | 208.7900 USD |
Sale | 100 | 210.0000 USD |
Sale | 100 | 210.0100 USD |
Sale | 101 | 209.5095 USD |
Sale | 200 | 210.0350 USD |
Sale | 200 | 209.5175 USD |
Sale | 217 | 209.9980 USD |
Sale | 300 | 209.0266 USD |
Sale | 300 | 208.9350 USD |
Sale | 553 | 207.3135 USD |
Sale | 581 | 209.2994 USD |
Sale | 698 | 209.9495 USD |
Sale | 896 | 208.8710 USD |
Sale | 1,043 | 208.9270 USD |
Sale | 1,075 | 209.6462 USD |
Sale | 1,685 | 209.8050 USD |
Sale | 1,834 | 208.9449 USD |
Sale | 1,900 | 209.2780 USD |
Sale | 1,900 | 210.6898 USD |
Sale | 1,999 | 208.9629 USD |
Sale | 2,154 | 208.6286 USD |
Sale | 2,320 | 208.5006 USD |
Sale | 2,447 | 208.7583 USD |
Sale | 2,500 | 208.4644 USD |
Sale | 3,100 | 208.4737 USD |
Sale | 3,683 | 208.9154 USD |
Sale | 4,906 | 208.1015 USD |
Sale | 5,046 | 207.2700 USD |
Sale | 6,068 | 207.3526 USD |
Sale | 6,900 | 210.2746 USD |
Sale | 10,013 | 209.3605 USD |
Sale | 11,294 | 211.0980 USD |
Sale | 24,196 | 209.1092 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 11 Sep 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200911005263/en/
Copyright Business Wire 2020
Related Shares:
Barclays